Bank of Hawaii’s Vertex Pharmaceuticals VRTX Stock Holding History

Bank of Hawaii’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,207	Closed	-$522K	–	271
2020 Q4	$522K	Sell	2,207 -1,140	-34%	-$262K	0.03%	197
2020 Q3	$911K	Buy	3,347 +937	+39%	+$259K	0.07%	138
2020 Q2	$700K	Sell	2,410 -2,705	-53%	-$733K	0.05%	157
2020 Q1	$1.22M	Sell	5,115 -2,265	-31%	-$520K	0.11%	112
2019 Q4	$1.62M	Sell	7,380 -1,047	-12%	-$212K	0.11%	112
2019 Q3	$1.43M	Buy	8,427 +98	+1%	+$17.3K	0.11%	119
2019 Q2	$1.53M	Buy	8,329 +792	+11%	+$138K	0.11%	114
2019 Q1	$1.39M	Buy	7,537 +3,347	+80%	+$618K	0.11%	122
2018 Q4	$694K	Sell	4,190 -655	-14%	-$113K	0.06%	186
2018 Q3	$934K	Buy	4,845 +955	+25%	+$170K	0.07%	176
2018 Q2	$661K	Buy	+3,890	New	+$603K	0.05%	201

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bank of Hawaii's VRTX Position: Q1 2021 in Review

Bank of Hawaii sold out of Vertex Pharmaceuticals (VRTX) in Q1 2021, closing a stake of 2,207 shares — an estimated $522K sold.

Bank of Hawaii first reported a position in VRTX in Q2 2018 and held it in 11 quarters. The position peaked at $1.62M in Q4 2019. 1,000 funds tracked by Wall St. Rank hold VRTX as of Q1 2021.

Bank of Hawaii reported no remaining Vertex Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Bank of Hawaii sold 2,207 Vertex Pharmaceuticals shares in Q1 2021, an estimated $522K.
Bank of Hawaii first reported a position in Vertex Pharmaceuticals in Q2 2018 and held it in 11 quarters.
Bank of Hawaii's Vertex Pharmaceuticals position peaked at $1.62M in Q4 2019.
1,000 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2021.

Based on Bank of Hawaii's 13F filing for Q1 2021, filed 13 May 2021.